Company intelligence / Profile preview

Translational Immunology

San Diego, California, United States

Ownership: Private
Development stage: Other

Overview

Translational Immunology is a biotechnology company focused on developing innovative therapies for autoimmune and inflammatory diseases. The company leverages deep expertise in immune system regulation to design targeted treatments that restore immune balance without broad immunosuppression. Their research primarily centers on modulating T-cell responses and cytokine signaling pathways to address high unmet medical needs in chronic inflammatory conditions. By bridging the gap between basic immunological research and clinical application, Translational Immunology aims to deliver precision medicines that improve patient outcomes.

Therapeutic areas: Immunology
Modalities: Monoclonal antibodySmall molecule
Industry: Biotech

Beyond the preview

Go deeper on Translational Immunology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Translational Immunology.

Explore the full profile